文献速递青光眼

用于检测青光眼相关肌纤蛋白的抗体:所见多于或少于表面

Antibodies Used to Detect Glaucoma-Associated Myocilin: More or Less Than Meets the Eye?
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本文讨论抗体试剂在检测肌纤蛋白(myocilin)时可能影响数据解读的问题,肌纤蛋白存在于小梁网并与部分遗传性青光眼相关;文章基于对肌纤蛋白结构及生物物理聚集特性的基本理解,提出下一代抗体试剂应具备特征的愿望清单。

要点

  • 抗体可能无法揭示样本全貌,研究者需了解可能影响或限制数据解读的抗体特性。
  • 联邦机构现要求受资助基金证明其如何验证所用试剂,并推动重组抗体应用。
  • 基于肌纤蛋白结构与聚集特性,文章提出下一代抗体的特征愿望清单。

核心结论

  • 长期而言,经过充分表征的靶向肌纤蛋白的抗体将有助于对其功能及在青光眼发病机制中作用的新认识。

研究设计与样本

  • 本文为讨论性文章,围绕抗体试剂在检测肌纤蛋白时的问题展开,并基于对肌纤蛋白结构及生物物理聚集特性的基本理解提出下一代抗体特征愿望清单。

主要发现

  • 抗体在生物医学研究中常用,但往往不能揭示样本的全部信息。
  • 联邦机构现要求受资助基金证明其如何验证所用试剂。
  • 噬菌体展示技术获2018年诺贝尔化学奖,推动重组抗体应用,可实现充分验证和固定DNA序列。
  • 肌纤蛋白存在于小梁网,并与部分遗传性青光眼相关。
  • 确认肌纤蛋白在组织和细胞培养中的表达已被采纳为小梁网研究的验证标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antibodies are key reagents used in vision research, indeed across biomedical research, but they often do not reveal the whole story about a sample. It is important for researchers to be aware of aspects of antibodies that may affect or limit data interpretation. Federal agencies now require funded grants to demonstrate how they will authenticate reagents used. There is also a push for recombinant antibodies, enabled by phage display technology awarded the 2018 Nobel Prize in Chemistry, which allow for thorough validation and a fixed DNA sequence. Here, we discuss how issues surrounding antibodies are pertinent to detecting myocilin, a protein found in trabecular meshwork and associated with a portion of hereditary glaucoma. Confirmation of myocilin expression in tissues and cell culture has been adopted as validation standard in trabecular meshwork research; thus, a discussion of antibody characteristics and fidelity is critical. Further, based on our basic structural understanding of myocilin architecture and its biophysical aggregation properties, we provide a wish list for the characteristics of next-generation antibody reagents for vision researchers. In the long term, well-characterized antibodies targeting myocilin will enable new insights into its function and involvement in glaucoma pathogenesis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Patterson-Orazem AC, Lieberman RL. Antibodies Used to Detect Glaucoma-Associated Myocilin: More or Less Than Meets the Eye? Invest Ophthalmol Vis Sci. 2019. PMID: 31067323. doi:10.1167/iovs.19-26843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。